Syngene International Limited (SYNGENE:NSE) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Syngene International Limited stock forecast from 0 analysts, the average analyst target price for Syngene International Limited is not available over the next 12 months. Syngene International Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Syngene International Limited is Neutral, which is based on 7 positive signals and 7 negative signals. At the last closing, Syngene International Limited’s stock price was INR 614.10. Syngene International Limited’s stock price has changed by -2.21% over the past week, -12.50% over the past month and -7.88% over the last year.
No recent analyst target price found for Syngene International Limited
No recent average analyst rating found for Syngene International Limited
Company Overview Syngene International Limited
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinical development services, as well as commercial manufacturing and sterile fill-finish services. It also provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services. In addition, the company offers chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics; biologics; and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization. It serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and other companies. The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited. Read Less
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal c...Read More
Frequently Asked Questions About Syngene International Limited (SYNGENE:NSE) Stock
Stock Target Advisor's fundamental analysis for Syngene International Limited's stock is Neutral.
SYNGENE:NSE stock's dividend yield is 0.20%.
Our analysis grades SYNGENE:NSE stock's dividend yield at F. This means that SYNGENE:NSE stock's dividend yield is above 33% of the stocks in the Diagnostics & Research sector in the NSE exchange.
Based on this SYNGENE:NSE may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on SYNGENE:NSE's stock to indicate what its average analyst target is.
SYNGENE:NSE stock's Price/Earning ratio is 50.81.
Our analysis grades SYNGENE:NSE stock's Price / Earning ratio at F. This means that SYNGENE:NSE stock's Price/Earning ratio is above 43.00000000000001% of the stocks in the Diagnostics & Research sector in the NSE exchange.
Based on this SYNGENE:NSE may be fairly valued for its sector
The last closing price of SYNGENE:NSE's stock was INR 614.10.
The most recent market capitalization for SYNGENE:NSE is INR 252.29B.
Unfortunately we do not have enough analyst data on SYNGENE:NSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Syngene International Limited's stock.
As per our most recent records Syngene International Limited has 0 Employees.
Syngene International Limited's registered address is Velankani Technology Park, Bengaluru, India, 560100.
You can get more information about it from Syngene International Limited's website at https://www.syngeneintl.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced on cashflow basis
The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Syngene International Limited (SYNGENE:NSE) Stock
Stock Target Advisor's fundamental analysis for Syngene International Limited's stock is Neutral.
SYNGENE:NSE stock's dividend yield is 0.20%.
Our analysis grades SYNGENE:NSE stock's dividend yield at F. This means that SYNGENE:NSE stock's dividend yield is above 33% of the stocks in the Diagnostics & Research sector in the NSE exchange.
Based on this SYNGENE:NSE may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on SYNGENE:NSE's stock to indicate what its average analyst target is.
SYNGENE:NSE stock's Price/Earning ratio is 50.81.
Our analysis grades SYNGENE:NSE stock's Price / Earning ratio at F. This means that SYNGENE:NSE stock's Price/Earning ratio is above 43.00000000000001% of the stocks in the Diagnostics & Research sector in the NSE exchange.
Based on this SYNGENE:NSE may be fairly valued for its sector
The last closing price of SYNGENE:NSE's stock was INR 614.10.
The most recent market capitalization for SYNGENE:NSE is INR 252.29B.
Unfortunately we do not have enough analyst data on SYNGENE:NSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Syngene International Limited's stock.
As per our most recent records Syngene International Limited has 0 Employees.
Syngene International Limited's registered address is Velankani Technology Park, Bengaluru, India, 560100.
You can get more information about it from Syngene International Limited's website at https://www.syngeneintl.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SYNGENE:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
